Cargando…
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Diffuse large B-cell lymphoma (DLBCL) exhibits significant genetic heterogeneity which contributes to drug resistance, necessitating development of novel therapeutic approaches. Pharmacological inhibitors of cyclin-dependent kinases (CDK) demonstrated pre-clinical activity in DLBCL, however many sta...
Autores principales: | Thieme, Elana, Bruss, Nur, Sun, Duanchen, Dominguez, Edward C., Coleman, Daniel, Liu, Tingting, Roleder, Carly, Martinez, Melissa, Garcia-Mansfield, Krystine, Ball, Brian, Pirrotte, Patrick, Wang, Lili, Xia, Zheng, Danilov, Alexey V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061728/ https://www.ncbi.nlm.nih.gov/pubmed/36998071 http://dx.doi.org/10.1186/s12943-023-01762-6 |
Ejemplares similares
-
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma
por: Thieme, Elana, et al.
Publicado: (2022) -
ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export
por: Boehringer, Ashley, et al.
Publicado: (2017) -
OMIC-05. PHOSPHOPROTEOMIC ANALYSIS IDENTIFIES SUBGROUP ENRICHED PATHWAYS AND KINASE SIGNATURES IN MEDULLOBLASTOMA
por: Leskoske, Kristin, et al.
Publicado: (2021) -
Circumventing the Greatwall
por: Short, Ben
Publicado: (2014) -
Proteomic analysis identifies plasma correlates of remote ischemic conditioning in the context of experimental traumatic brain injury
por: Saber, Maha, et al.
Publicado: (2020)